The impact of immunochemical faecal occult blood testing on colorectal cancer incidence

Digestive and Liver Disease

Volumn 46, Issue 1, 2014, Pages 82-86

  Ventura, Leonardo ^a   Mantellini, Paola ^a   Grazzini, Grazia ^a   Castiglione, Guido ^a   Buzzoni, Carlotta ^a   Rubeca, Tiziana ^a   Sacchettini, Claudio ^a   Paci, Eugenio ^a   Zappa, Marco ^a  

^a Cancer Prevention and Research Institute   (Italy)

Author keywords

Colorectal cancer; Incidence; Screening

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; COLORECTAL CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OCCULT BLOOD; PRIORITY JOURNAL;

COLORECTAL CANCER; INCIDENCE; SCREENING;

AGED; COHORT STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOCHEMISTRY; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PROPORTIONAL HAZARDS MODELS;

EID: 84892369993     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2013.07.017     Document Type: Article

References (24)

1. http://www.cancer.org/Healthy/FindCancerEarly/CancerScreeningGuidelines/american-cancer-society-guidelines-for-the-early-detection-of-cancer.
2. Mandel J.S., Church T.R., Bond J.H., et al. The effect of faecal occult-blood screening on the incidence of colorectal cancer. The New England Journal of Medicine 2000, 343:1603-1607.
3. van Rossum L.G., van Rijn A.F., Laheij R.J., et al. Random comparison of guaiac and immunochemical faecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008, 135:82-90.
4. Atkin W.S., Edwards R., Kralj-Hans I., et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomized controlled trial. Lancet 2010, 375:1624-1633. UK Flexible Sigmoidoscopy Trial Investigators.
5. Segnan N., Armaroli P., Bonelli L., et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian randomized controlled trial-SCORE. Journal of the National Cancer Institute 2011, 103:1310-1322. SCORE Working Group.
6. Lansdorp-Vogelaar I., van Ballegooijen M., Zauber A.G., et al. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. Journal of the National Cancer Institute 2009, 101:1412-1422.
7. Ventura L., Zappa M., Carreras G., et al. What is the best screening strategy to detect advanced colorectal adenomas? Simulation from ongoing Italian screening experiences. Tumori 2011, 97:547-550.
8. Zappa M., Castiglione G., Grazzini G., et al. Effect of faecal occult blood testing on colorectal mortality: results of a population-based case-control study in the district of Florence, Italy. International Journal of Cancer 1997, 73:208-210.
9. Castiglione G., Zappa M., Grazzini G., et al. Immunochemical vs guaiac faecal occult blood tests in a population-based screening program for colorectal cancer. British Journal of Cancer 1996, 74:141-144.
10. Hol L., van Leerdam M.E., van Ballegooijen M., et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy. Gut 2010, 59:62-68.
11. Costantini A.S., Martini A., Puliti D., et al. Colorectal cancer mortality in two areas of Tuscany with different screening exposures. Journal of the National Cancer Institute 2008, 100:1818-1821.
12. Zappa M., Castiglione G., Giorgi D., et al. Re: Participation in colorectal cancer screening: a review. Journal of the National Cancer Institute 1998, 90:465.
13. Crocetti E., Buzzoni C., Zappa M. Colorectal cancer incidence rates have decreased in central Italy. European Journal of Cancer Prevention 2010, 19:424-425.
14. (28.03.2013). http://itacan.ispo.toscana.it/italian/itacan.htm.
15. Grazzini G., Castiglione G., Isu A., et al. Colorectal cancer screening by faecal occult blood testing: results of a population-based experience. Tumori 2000, 86:384-388.
16. StataCorp Stata Statistical Software: Release 12 2011, StataCorp LP, College Station, TX.
17. The UK CRC Screening Pilot Evaluation Team. Evaluation of the UK Colorectal Cancer Screening Pilot. Final Report, 2003.
18. Faggiano F., Partanen T., Kogevinas M., et al. Socioeconomic differences in cancer incidence and mortality. IARC Scientific Publications 1997, 138:65-176.
19. Spadea T., D'Errico A., Demaria M., et al. Educational inequalities in cancer incidence in Turin, Italy. European Journal of Cancer Prevention 2009, 18:169-178.
20. Rapporto nazionale Passi 2011: lo screening per il cancro del colon retto.
21. Saito H., Soma Y., Koeda J., et al. Reduction in risk of mortality from colorectal cancer by faecal occult blood screening with immunochemical hemagglutination test. A case-control study. International Journal of Cancer 1995, 16:61. 465-9.
22. van Rossum L.G.M., van Rijn A.F., Laheij R.J.F., et al. Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening program. British Journal of Cancer 2009, 101:1274-1281.
23. Grazzini G., Visioli C.B., Zorzi M., et al. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?. British Journal of Cancer 2009, 100:259-265.
24. Guittet L., Bouvier V., Mariotte N., et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007, 56:210-214.